Cluster
The GLP-1 Effect on Spirits
TL;DR
Ozempic, Wegovy, and Mounjaro are reshaping alcohol consumption. Forecast how Big Six earnings calls, volume guidance, and retail data shift.
Every major spirits CEO now fields GLP-1 questions on earnings calls. The clinical data is real, the consumer behavior is messier, and the long-term volume impact is the most-debated number on Wall Street. These markets put a probability on the next twelve months of guidance and disclosure.
4 open markets
Flashcloses in 86d
Awards
Will any 2026 Spirited Award speech reference Ozempic, GLP-1, or weight-loss medications?
popglp1spirited_awards
Crowd
no predictions yet
Predictors
0
Issuescloses in 241d
Will any Big 6 spirits CEO name GLP-1 medications as a material headwind on a 2026 earnings call?
glp1ozempicearningsbig6
Crowd
75% YES
Predictors
1+1/24h
Issuescloses in 241d
Will US off-premise alcohol dollar sales decline year-over-year for three consecutive Circana four-week periods in 2026?
glp1off_premisecircanadata
Crowd
no predictions yet
Predictors
0
Hospitalitycloses in 241d
Will a major hospitality publication run a feature on Ozempic menus in 2026?
glp1editorialmenustrend
Crowd
no predictions yet
Predictors
0
Other clusters
Bourbon Glut
American whiskey is sitting on a record stockpile.
Tequila Crisis
Agave prices crashed and category growth flipped negative.
THC vs Alcohol
Hemp-derived THC drinks are the fastest-growing beverage segment.
Celebrity Spirits
The celebrity-brand bubble is deflating.
Tariffs & Trade
EU snapback tariffs and global trade fights are existential for American whiskey and tequila.
Tipping Wars
Service charges, no-tipping models, and gratuity reform are the loudest debates in hospitality.
AI in Hospitality
AI agents, voice ordering, and automated reservations are showing up across the industry.